New Investor as of July 2013, but small biotech Investor.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Absolutely. I didn’t mean to harp on. Just wanted to clarify! Peace. !
But a FB poster just said she is ‘helping’ on an as-need basis.
Well, I got a direct message on twitter from her saying she is not. And I removed my tweet per her request.
Not sure if already said, but I got a DM on Twitter from Melissa. She is NOT the new media person.
Awesome! And with potential EUA, or any of the other three country’s approvals, things are looking up!
Awesome. Glad to see people keeping up on the good due diligence! Thanks Bio! Didn’t see your post until now!
Cytodyn’s New Media Director? https://www.melissadodd.com/
Totally respect your opinion, 3X. And I’ve always said that the PR area could use some tweaking. No denying that. But I really think Cytodyn at this moment has the US by the short hairs... Would trump or any President get caught with their pants down allowing a US made drug, get approval overseas with clearly demonstrated safety and efficacy in time of a pandemic? You don’t need a lobbyist when you have that kind of clout on your side.
If we were talking before Covid, I would be cheering on PR more.
But it’s all good. We all want this company to succeed. Here’s hoping we see great things by December!
Peace.
They are not perfect. But NO company is. And they have done amazingly with the 10 employees they have. That was just a small list just reviewing past PRs.
And near bankruptcy turn around is another.
Agreed. This was a fantastic write up.
Gee...
I mean, in two years under NP, they completed HIV Combo, Started a Cancer Trial, then upgraded it to basket trial, started and finished a mild/moderate Covid Trial during a “pandemic”AND started and halfway filled a moderate/severe Covid trial, secured Samsung for manufacturing, secured Vyera pharmaceuticals for commercialization for HIV, filed for Nasdaq up listing, secured a team of first class medical experts in multiple fields, secured American Regent for distribution for US Covid distribution, initiated a trial for Nash, initiated a GvHD Trial, and more, secured funding, all the while having to correct a poly sci Twitter bully who unethically contacts cancer patients for exploitation, all while fighting an uphill battle with the fda, and with only 10 employees.
Sh*t, I wish this company would actually get stuff done.
Never said there WAS nasdaq news, just mentioning things to come. Hope that was clear.
My personal opinion on what will solidly move the needle is uplist AND approval.
The waiting game is what it is. All good things to come for those who are patient. Such is early biotech life.
Peace, Grip.
Lol. Exactly. I thought it was actually very informative. And NP is right. He said the exact same thing I said yesterday... if you don’t see the results as positive, you either can’t read, are in complete denial, or can’t comprehend what the results are communicating.
If Leronlimab can produce such positive results in a trial group that is a challenge to measure substantial responses in, imagine what it is doing in the severe trial.
Exactly. Nasdaq news, approval or phase 2/3 results... all good things coming.
Yep. Until uplist and approval, drops in sp are an opportunity to buy imo.
Ha ha chuckles! Those are some pretty accurate statistics! Lol.
Hey everyone! Quotations around words makes them “legitimate”! See what I did there?
But the data revealed in the Leronlimab mild/moderate trial is undeniable. The rationale for approval is solid. And all it takes is one approval and this thing is flying.
See you in December!
This may also be a reason why they’ve never had AF interviewed by Dr. Yo or anyone else on the clinical aspect of Leronlimab and it’s positive clinical impact. LMAO!
This is why the phase three moderate/severe trial is going to have so much more impact.
True. But one rule of clinical outcomes is never assume an outcome if the data is not there. That was my point. Couple that with reduction in SAEs and it is laughable to think that improvement failed after day 3. Only someone with absolutely no common sense or medical background would make such statements.
Exactly. But some would think it’s better to be improved clinically at day 14 than day 3. Imagine that idiocy.
Share price is meaningless at this point. But thanks for proving you had no proof.
See you in December!
“Then fizzled out”
No proof. Just insinuation.
Wow. You actually read it in its entirety? Lol. Wish everyone would.
Is next week the third week of August?
Play stupid games, win stupid prizes.
The deflection is thinking that there is a deflection in Holly. Medical professionals and those with patient centered focus know that there is an integrity and ethical issue that needs addressed, totally separate from any market movements.
Yikes. I mean, I know that it is a known drug for birth defects in child-bearing ages. But never did enough research to know if it was still applied elsewhere.
Didn’t Billy Joel already talk about this? But seriously, I can’t read the article because it blacks out. Are we still using thalidomide today? Crazy. Just another reason that safe, therapeutics is a better way to go. AND if Leronlimab boosts the immune system to ramp up antibody production, it’s a win-win.
Yup! Covid results, if as fantastic as we all believe, will be a confirmation of what is a triple threat: HIV, Cancer, and Inflammatory conditions. Black Ops is correct in that this will be a major blockbuster like has never been seen if this drug comes to full fruition. Time is on our side, and I believe the results are also.
I’m no doctor, but any other symptoms? This almost smells of guillian barre syndrome.
Most Indubitably.
There’s a reason why she’s not responding to AF. Maybe he should take a good long look in the mirror as to why.
Instead of focusing on someone whose labs and results are not public information, maybe he should pick on trial data, instead of a lady battling cancer that he’s exploiting.
You have to be a legitimate reporter to ask a legitimate question. Legitimacy requires more than credentials, it requires character.
Just knowing that makes me happy. That’s because this firestorm called Leronlimab is about to crack its way into the medical world like a tree root through a basement... it may have been slow, will crack and give way to the pressure. This drug will move mountains, and I for one will be happy to see AF proven wrong. He has no morals, or common decency. I can’t imagine what challenges his kids have with their last name being the F word. Must be a hard legacy to shake, unless they turn out just like him.
Yep, AF is the Jerry Springer of biotech writing. I felt sorry for AFs mother in law after she died. But then again, one can’t always choose their son in laws.
Exactly. Can’t imagine what my portfolio will look like ten years from now.
Just think of how much positive Covid news translates into every other inflammatory indication. THAT is why $10 is low thinking.
The silence is deafening.
Where did you see actual documentation of outright rejection from the Nasdaq to Cytodyn?
Game on!